A writer called @aaditsh posted a thread on X about a telehealth company called Medvi. He had spent five to six years studying how stories move online, and this was one he said he could not stop thinking about. Having spent 15 years in strategy, I could not stop thinking about it either.
Here is the version that circulated: Medvi sells compounded GLP-1 weight-loss injections for $299 a month, when pharmacies charge $1,300 or more. That pricing gap drove $401 million in their first year. For 2026, they are projecting $1.8 billion, with two employees. The New York Times profiled it as the AI success story of the decade. Sam Altman's prediction of the one-person billion-dollar company had, apparently, come true.
There was a genuine arbitrage
Before getting to what came next, it is worth holding onto this: the underlying business model has logic. A $299 a month price point against a $1,300 pharmacy equivalent is a real gap in a drug category genuinely transforming healthcare. That part of the story is true.
The X thread covered Medvi's pricing in detail. The GLP-1 weight-loss market is enormous and the access barriers are real. If you can bring the cost down by 75%, people will come. That is not a narrative. That is arithmetic.
How the story moved
A thread on X became a New York Times feature became the definitive AI success story of the moment. @aaditsh tracked the mechanics of how it happened: each retelling amplified the last, the frame tightened with every pass, and by the time the story had done its job, checking it felt almost beside the point.
This is the pattern he had been watching for years. Not specific to Medvi. Specific to how narratives move in 2026. A single viral moment seeds a frame. The frame gets picked up by a credible outlet. The credible outlet signals that verification has already happened. Nobody re-checks what the credible outlet did not check. The story becomes settled fact.
But weeks before the NYT piece ran, the FDA had sent Medvi a warning letter. Misbranding violations. Customer reviews already showing bait-and-switch prescriptions. Facebook profiles of fake doctors advertising Medvi. Real physicians publicly asking to be removed from a platform they had never joined.
@aaditsh was careful about this. His words: "I'm not saying Medvi is a scam. I genuinely don't know enough to say that. What I am saying is: the narrative moved faster than the diligence."
The hidden layer nobody mentioned
There is one more detail from @aaditsh's thread that almost no one picked up on. The "two employees" story is technically accurate and categorically misleading at the same time.
The entire operation runs on OpenLoop Health, an infrastructure startup based in Iowa that quietly powers dozens of telehealth companies. Nobody is really saying that. The "one person billion-dollar company" story is doing more work than the actual business model right now. Medvi is not really an AI company that hit $1 billion. It is a medical business that used AI. The infrastructure underneath tells you more about the model than the headline on top.
Three signals worth tracking (Mike's read)
What follows is my own interpretation, not from @aaditsh's thread.
1. Narrative velocity is a risk factor, not just an asset. The same speed that builds a company's profile can destroy it. Being first to shape the frame matters enormously. Being last to correct it can be catastrophic. Every brand, every founder, every communications team should be asking: how fast is our story moving, and is the reality behind it keeping pace?
2. "AI company" is the most over-applied label in business right now. Using AI in your stack does not make you an AI company. That matters because investors, journalists, and the public are pattern-matching to "AI company" and applying a completely different valuation logic. When the infrastructure underneath is a conventional medical services business, the label is doing work the fundamentals cannot support.
3. The editorial accountability gap is widening. The distance between "story published" and "story checked" keeps growing. Social to tier-one outlet is a pipeline with almost no friction now. That gap is where reputations are both made and destroyed. The companies that understand this are the ones actively managing it. The ones that do not are hoping the narrative holds.
Why this matters for strategy
I built a deck around this case study because it crystallises something I think is genuinely important right now. Not just for startups. For anyone who builds, sells, or communicates anything.
Narrative is probably the most powerful tool in business today. It raises your round. It attracts your talent. It sets your valuation. It gets you the NYT profile. And when it gets ahead of reality, it becomes the thing that takes you down.
Two things can be true at once. Medvi may have found a real arbitrage in GLP-1 pricing. And the "one person billion-dollar company" story may be doing more work than the actual business model right now. Those are not contradictions. They are the same story, in different phases.
The question is always: what happens when the phases catch up with each other?
